Abstract
The outcome of 12 children with classical maple syrup urine disease is reviewed. All patients presented in the neonatal period at ages varying from 5 to 21 (median 8) days. The time taken to make the diagnosis ranged from 1 day to longer than 9 months (median 7 days). Each survived his initial illness but 3 died later after apparently mild infections. Three of the 12 patients had a spastic quadriplegia and 6 others abnormal neurological signs without clear cerebral palsy. The single most important factor determining the outcome appears to be the time taken to make the diagnosis after the first symptoms. Two patients were diagnosed within 24 hours of the first symptoms and one is of above average ability. The other is mildly retarded but control of the disease was poor in his first 4 years of life. Outcome is unpredictable if the delay is between 3 and 14 days. Two children are of normal ability but 6 others are retarded. A delay longer than 14 days is invariably associated with mental retardation and cerebral palsy. We conclude that early diagnosis is essential to improve the outcome of this condition.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clow C. L., Reade T. M., Scriver C. R. Outcome of early and long-term management of classical maple syrup urine disease. Pediatrics. 1981 Dec;68(6):856–862. [PubMed] [Google Scholar]
- Dancis J., Hutzler J., Rokkones T. Intermittent branched-chain ketonuria. Variant of maple-syrup-urine disease. N Engl J Med. 1967 Jan 12;276(2):84–89. doi: 10.1056/NEJM196701122760204. [DOI] [PubMed] [Google Scholar]
- Dickinson J. P., Holton J. B., Lewis G. M., Littlewood J. M., Steel A. E. Maple syrup urine disease. Four years' experience with dietary treatment of a case. Acta Paediatr Scand. 1969 Jul;58(4):341–351. doi: 10.1111/j.1651-2227.1969.tb04730.x. [DOI] [PubMed] [Google Scholar]
- KIIL R., ROKKONES T. LATE MANIFESTING VARIANT OF BRANCHED-CHAIN KETOACIDURIA (MAPLE SYRUP URINE DISEASE). Acta Paediatr. 1964 Jul;53:356–364. doi: 10.1111/j.1651-2227.1964.tb07789.x. [DOI] [PubMed] [Google Scholar]
- MACKENZIE D. Y., WOOLF L. I. Maple syrup urine disease; an inborn error of the metabolism of valine, leucine, and isoleucine associated with gross mental deficiency. Br Med J. 1959 Jan 10;1(5114):90–91. doi: 10.1136/bmj.1.5114.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MENKES J. H., HURST P. L., CRAIG J. M. A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics. 1954 Nov;14(5):462–467. [PubMed] [Google Scholar]
- Naylor E. W., Guthrie R. Newborn screening for maple syrup urine disease (branched-chain ketoaciduria). Pediatrics. 1978 Feb;61(2):262–266. [PubMed] [Google Scholar]
- Pohlandt F. Plasma amino acid concentrations in newborn infants breast-fed ad libitum. J Pediatr. 1978 Apr;92(4):614–616. doi: 10.1016/s0022-3476(78)80305-9. [DOI] [PubMed] [Google Scholar]